ACM Research, Inc.

ACM Research is a US-listed Chinese semiconductor-equipment company — wet-etch, cleaning, and advanced-packaging tools sold to leading-edge Chinese fabs (CXMT, SMIC, Yangtze Memory) and increasingly to non-China customers. It's the specific way to own the China-onshoring-semi-fab cycle from a US-listed vehicle.

• The Q2 print was a genuine blowout: revenue of $292.9M grew 36% YoY beating the $269M estimate, EPS of $1.23 crushed the $0.42 consensus by nearly 3x, gross margin held at 46%, and management raised the FY26 guide — that magnitude of beat on already-strong numbers is the specific setup that gets multiple expansion.
• The order book confirms the durability: orders up 105% YoY as ACMR expands from wet-etch/cleaning into advanced-packaging and delivers to CXMT and (per the sentiment note) Intel — the latter is a specific western-customer win that changes the perception of ACMR as purely a China-domestic play.
• The analyst response validates the tape: JPM raised to $110, Goldman to $164 — both meaningfully above the current $81 print, framing ACMR as a "platform in the making." The valuation at 55x TTM PE is stretched, but consensus FY26 EPS of $2.00 puts the forward at ~41x, defensible if the order-flow trajectory continues.

What extends the run is the Nov 4 print confirming order-flow momentum and specific commentary on Intel/CXMT ramp cadence; what interrupts it is a US-China chip-export policy escalation that constrains ACMR's ability to serve western customers, or a customer-capex pause from CXMT or Yangtze Memory.